BOSTON SCIENTIFIC CORPORATION
Clinical trial NCT04468360 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2026-12-01 → 2025-04-29 3. primary completion date: 2026-12-01 → 2025-04-29 4. enrollment: 256 → 11 participants 5. enrollment type: ESTIMATED → ACTUAL 6. allocation: RANDOMIZED → NON_RANDOMIZED 7. intervention model: PARALLEL → SEQUENTIAL 8. primary purpose: BASIC_SCIENCE → OTHER 9. masking: TRIPLE → NONE
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical